Company news
Optimind Pharma Corp. (CSE:OMND) news
Every Optimind Pharma Corp. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Optimind Pharma Announces Adoption of Semi-Annual Reporting
July 24, 2026
Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk
September 8, 2025
Optimind Pharma Announces Termination of Letter of Intent
September 4, 2025
Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business
March 24, 2025
Optimind Pharma Closes Second Tranche of Private Placement
July 29, 2024
Optimind Pharma Closes First Tranche of Private Placement
July 8, 2024
Optimind Pharma - Private Placement
July 3, 2024
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
October 12, 2023
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
September 21, 2022